Pulse Biosciences, Inc. (PLSE)
NASDAQ·Healthcare·Medical - Instruments & Supplies
$21.75
-3.97%
Mkt Cap $1.66B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 19, 2026 | $150.00K | $264.00K | +76.00% | -$0.27 | -$0.26 | +1.89% | — | — |
| Q4 2025 Nov 5, 2025 | $225.00K | $86.00K | -61.78% | -$0.31 | -$0.29 | +6.45% | — | — |
| Q3 2025 Aug 12, 2025 | $500.00K | — | — | -$0.26 | -$0.28 | -7.69% | — | — |
| Q2 2025 May 8, 2025 | — | — | — | — | -$0.17 | — | — | — |
| Q1 2025 Mar 27, 2025 | — | $1.66M | — | -$0.24 | -$0.17 | +29.17% | — | — |
| Q4 2024 Oct 30, 2024 | — | — | — | -$0.24 | -$0.16 | +33.33% | — | — |
| Q3 2024 Aug 19, 2024 | — | — | — | -$0.24 | -$0.20 | +17.05% | — | — |
| Q2 2024 May 7, 2024 | — | — | — | -$0.24 | -$0.14 | +41.67% | — | — |
| Q1 2024 Mar 28, 2024 | — | $1.74M | — | -$0.24 | -$0.15 | +37.50% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$0.24 | -$0.15 | +37.50% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.22 | -$0.19 | +13.64% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$0.22 | -$0.23 | -4.55% | — | — |
| Q1 2023 Mar 30, 2023 | $200.00K | -$9.00K | -104.50% | -$0.24 | -$0.22 | +8.33% | — | — |
| Q4 2022 Nov 10, 2022 | $200.00K | — | — | -$0.45 | -$0.46 | -2.22% | — | — |
| Q3 2022 Aug 10, 2022 | $439.67K | $265.00K | -39.73% | -$0.37 | -$0.37 | +0.00% | — | — |
| Q2 2022 May 11, 2022 | $715.33K | $444.00K | -37.93% | -$0.51 | -$0.48 | +5.88% | — | — |
| Q1 2022 Mar 31, 2022 | $872.00K | $844.00K | -3.21% | -$0.50 | -$0.39 | +22.00% | — | — |
| Q4 2021 Nov 15, 2021 | $860.00K | $574.00K | -33.26% | -$0.54 | -$0.42 | +22.22% | — | — |
| Q3 2021 Aug 9, 2021 | $30.00K | — | — | -$0.79 | -$0.48 | +39.24% | — | — |
| Q2 2021 May 10, 2021 | — | — | — | -$0.52 | -$0.43 | +17.31% | — | — |